Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class: Equity / Ordinary Shares / American Depositary Shares
Shares outstanding: 384,317,619
Number of holders: 13
Total 13F shares, excl. options: 3,241,493
Shares change: +152,673
Total reported value, excl. options: $35,915,000
Value change: +$733,099
Number of buys: 6
Number of sells: -8
Price: $11.08

Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q3 2021

17 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q3 2021.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3,241,493 shares of 384,317,619 outstanding shares and own 0.84% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2,578,174 shares), Ikarian Capital, LLC (285,264 shares), ARK Investment Management LLC (180,523 shares), ADVISOR GROUP HOLDINGS, INC. (54,821 shares), BOOTHBAY FUND MANAGEMENT, LLC (43,459 shares), MEITAV DASH INVESTMENTS LTD (37,567 shares), STATE STREET CORP (30,504 shares), GEODE CAPITAL MANAGEMENT, LLC (13,738 shares), Apollon Wealth Management, LLC (12,000 shares), and Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. (3,097 shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.